Related Experiment Video
Updated: Jun 25, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
An exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose
Keira P Mason1, Steven Zgleszewski, Roberta E Forman
1Department of Anesthesia, Perioperative and Pain Medicine, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA. keira.mason@childrens.harvard.edu
Abstract:
At our institution, high-dose i.v. dexmedetomidine is used to provide sedation for pediatric patients undergoing nonpainful radiological imaging studies. Some of these patients exhibit marked bradycardia (more than 20% deviation from the lowest age-adjusted normal values) while maintaining an arterial blood pressure within an acceptable normal range. We report on three cases wherein treatment of dexmedetomidine-induced bradycardia with i.v. glycopyrrolate (5.0 microg/kg) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Toxidromes: Clinical Features
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Desensitization and Tachyphylaxis
Several...
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...